Wutah dodolan YoY sajrone rolas wulan kepungkur: Akero Corp (AKRO)

Logo grafis Akero Corp (AKRO)

Akero Therapeutics (AKRO) relies on the potential of efruxifermin and M&A prospects within the MASH segment. The LTM annual sales volume change on this chart from GURU.Markets confirms the trend, where this metric equals 0.00. Strong management under Andrew Cheng ensures success, while GMP-standardized production facilities guarantee the high quality of the biopharmaceutical products being released.

Wutah dodolan YoY sajrone rolas wulan kepungkur: Akero Therapeutics Inc (AKRO) kanggo 11.02.2024 - 20.12.2025

akerotx.com (AKRO) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi bursa perusahaan:
Analisis kabeh metrik perusahaan:AKRO (Akero Therapeutics Inc)
Produk seri Akero Therapeutics

Diversifying the clinical trial portfolio for metabolic drugs minimizes systemic risks for Akero Therapeutics (AKRO). This metric captures revenue dynamics over the last twelve months relative to the same period last year, measuring the pace of business expansion. It is critical for investors to compare this growth with the market valuation to avoid overpaying for the asset at its peak price. An analysis of the TTM sales volume change confirms the issuer's actual operational capacity.

Karo sapa Akero Therapeutics saingan

Ascendis (ASND) - Wutah pendapatan taun lumaku|MDGL - Wutah dodolan YoY sajrone rolas wulan kepungkur|CORT: Wutah dodolan YoY sajrone rolas wulan kepungkur|RYTM: Wutah dodolan YoY (TTM)|MTSR - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur MoonLake Corp|Crinetics Corp (CRNX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur newamsterdampharma.com (NAMS)|Wutah pendapatan YoY sajrone 12 wulan kepungkur soleno.life SLNO|Wutah dodolan YoY (TTM) FOLD (amicusrx.com)|Wutah pendapatan taunan sajrone rolas wulan kepungkur 89bio (ETNB)|Agios - Wutah dodolan YoY (TTM)|Structure Corp - Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur|mimedx.com (MDXG) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah dodolan taun lumaku RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur MBX|Wutah dodolan YoY sajrone rolas wulan kepungkur Altimmune Pharma (ALT)|Wutah dodolan YoY sajrone rolas wulan kepungkur AARD (Aardvark Therapeutics Corp)|Wutah dodolan YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Wutah pendapatan taun lumaku|BMEA: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Dinamika pendapatan YoY sajrone rolas wulan kepungkur QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|vTv Therapeutics, Inc. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Agape ATP Corp.|Wutah pendapatan YoY sajrone 12 wulan kepungkur Pluri (PLUR)|Wutah dodolan YoY (TTM) SYBX|Wutah pendapatan taunan sajrone rolas wulan kepungkur Lipocine Inc|Wutah dodolan YoY sajrone rolas wulan kepungkur Matinas BioPharma Holdings MTNB|Wutah pendapatan taunan sajrone rolas wulan kepungkur Spruce Biosciences (SPRB)|GLTO: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan taun lumaku CTCX|LUMO (Lumos Pharma) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY sajrone 12 wulan kepungkur ONVO|RDUS (Radius Pharmaceuticals) - Wutah dodolan YoY (TTM)